Rao, Qi
Zhu, Hong
Jin, Lu
Zhu, Huaijun
Wu, Fang
Zhou, Jie
Zhang, Jinping
Wang, Siliang
Liu, Mengying
Funding for this research was provided by:
clinical trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University (2022-LCYJ-PY-48 ;2023-LCYJ-MS-32)
the Hospital Pharmacy Department of the Chinese Pharmaceutical Association (CPA-Z05-ZC-2023002)
Article History
Received: 3 June 2025
Accepted: 5 August 2025
First Online: 14 October 2025
Declarations
:
: The authors declare no competing interests.
: This study was approved by the Ethics Committee of Nanjing Drum Tower Hospital (approval number: 2021-583-01) and was registered at ClinicalTrials.gov (NCT05665478). Written informed consent was obtained from all participants, and the study complied with the Declaration of Helsinki.